<DOC>
	<DOCNO>NCT02795117</DOCNO>
	<brief_summary>The purpose study compare safety efficacy Perrigo 's product FDA approve product treatment inflammatory lesion rosacea</brief_summary>
	<brief_title>Comparative Safety Efficacy Two Treatments Treatment Inflammatory Lesions Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<criteria>1 . Must sign Institutional Review Board ( IRB ) approve write inform consent study . 2 . Must least 18 year age 3 . Must definite clinical diagnosis moderate severe facial papulopustular rosacea 4 . Subjects must willing able understand comply requirement study apply medication instruct . 5 . Subjects must general good health free clinically significant disease , rosacea , might interfere study evaluation . 6 . Females childbearing potential ( exclude woman surgically sterilize ( verified tubal ligation bilateral oophorectomy hysterectomy ) post menopausal least 2 year ) , addition negative urine pregnancy test Visit 1/Day 1 ( Baseline ) , must willing use acceptable form birth control study . 1 . Subjects , pregnant , breastfeeding , plan pregnancy within period study participation . 2 . Current past ocular rosacea . 3 . Presence facial skin condition might interfere rosacea diagnosis and/or assessment . 4 . History hypersensitivity allergy study medication and/or ingredient study medication . 5 . Use radiation therapy and/or antineoplastic agent within 90 day prior Visit 1/Day 1 ( Baseline ) . 6 . Current use anticoagulation therapy use throughout study . 7 . Use medicate makeup ( include antiaging makeup ) throughout study 8 . Use study 1 ) systemic steroid , 2 ) topical retinoids face 3 ) antibiotic know impact rosacea 4 ) immunosuppressive agent , immunomodulators ) . 9 . Facial use 1 ) topical steroid , 2 ) topical antiinflammatory agent , 3 ) topical antimycotic , 4 ) topical rosacea treatment 4 ) topical antibiotic . 10 . Use medicate cleanser face ( throughout study . 11 . Subject consumes excessive alcohol , abuse drug , condition could compromise subject 's ability comply study requirement 12 . Use topical astringent abrasive , medicate topical preparation ( prescription OTC product ) within 2 day prior Visit 1 throughout study . 13 . Use antipruritic ( include antihistamine ) , spa treatment chlorine exposure ( swim etc . ) within 24 hour study visit . 14 . Participation clinical study involve investigational product , agent device might influence intended effect mask side effect study medication 1 month ( 30 day ) prior Visit 1/Day 1 ( Baseline ) throughout study . 15 . Previous enrollment study current enrollment study another participate site . 16 . Use tanning booth , sun lamp ( excessive UV radiation e.g. , phototherapy , daily extend exposure occupational exposure sun ) , sunbathe excessive exposure sun 1 week prior baseline throughout study . 17 . Subjects opinion investigator , unlikely able follow restriction protocol complete study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>